Surprisingly, however, individuals with metabolic disorders such as obesity, T2DM and fatty liver have high levels of FGF21 and respond poorly to exogenous FGF21, this phenomenon was defined as FGF21 resistance. The gene discussed is FGF21; the disease is obesity disorder.